Sarcoidosis clinical trials at UCLA

1 research study open to eligible people

Showing trials for

  • BMS-986278 in Participants With Progressive Pulmonary Fibrosis

    open to eligible people ages 21 years and up

    The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.

    Los Angeles 5368361, California 5332921 and other locations

Our lead scientists for Sarcoidosis research studies include .

Last updated: